医中誌リンクサービス


文献リスト

1)McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984; 34: 939-44
PubMed CrossRef
医中誌リンクサービス
2)Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology. 2001; 56: 1143-53
PubMed CrossRef
医中誌リンクサービス
3)Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimers Asso-ciation workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 257-62
PubMed CrossRef
医中誌リンクサービス
4)McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 263-9
PubMed CrossRef
医中誌リンクサービス
5)Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Asso-ciation workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 270-9
PubMed CrossRef
医中誌リンクサービス
6)Sperling RA, Aisen PS, Beckett LA, et al. Towards defining the preclinical stagse of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement. 2011; 7: 280-92
医中誌リンクサービス
7)Hampel H, Burger K, Teipel SJ, et al. Core candidate neurochemical and imaging biomarkers of Alzheimers disease. Alzheimers Dement. 2008; 4: 38-48
PubMed CrossRef
医中誌リンクサービス
8)Jack Jr CR, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment. Brain. 2008; 131: 665-80
PubMed CrossRef
医中誌リンクサービス
9)Chetelat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010; 67: 317-24
PubMed
医中誌リンクサービス
10)McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984; 34: 939-44
PubMed CrossRef
医中誌リンクサービス
11)Burns A, Luthert P, Levy R, et al. Accuracy of clinical diagnosis of Alzheimers disease. BMJ. 1990; 301: 1026
PubMed
医中誌リンクサービス
12)Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimers pathological cascade. Lancet Neurol. 2010; 9: 119-28
PubMed CrossRef
医中誌リンクサービス
13)Fagan AM, Head D, Shah AR, et al. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol. 2009; 65: 176-83
PubMed CrossRef
医中誌リンクサービス
14)McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005; 65: 1863-72
PubMed CrossRef
医中誌リンクサービス
15)Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993; 43: 250-60
PubMed CrossRef
医中誌リンクサービス
16)Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007; 21: S14-8
PubMed CrossRef
医中誌リンクサービス
17)Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54
PubMed CrossRef
医中誌リンクサービス
18)McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of fronto-temporal dementia: report of the Work Group on Frontotemporal Dementia and Picks Disease. Arch Neurol. 2001; 58: 1803-9
PubMed CrossRef
医中誌リンクサービス
19)Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76: 1006-14
PubMed CrossRef
医中誌リンクサービス
20)Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6: 734-46
PubMed CrossRef
医中誌リンクサービス
21)Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimers disease. Brain. 2007; 130: 2636-45
PubMed CrossRef
医中誌リンクサービス
22)Rabinovici GD, Jagust WJ, Furst AJ, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol. 2008; 64: 388-401
PubMed CrossRef
医中誌リンクサービス
23)Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimers disease. Alzheimers Disease Centers Consortium on Apolipoprotein E and Alzheimers Disease. N Engl J Med. 1998; 338: 506-11
PubMed CrossRef
医中誌リンクサービス
24)Schellenberg G. Early Alzheimers disease genetics. J Alzheimers Dis. 2006; 9: 367-72
PubMed
医中誌リンクサービス
25)Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimers pathological cascade. Lancet Neurol. 2010; 9: 119-28
PubMed CrossRef
医中誌リンクサービス
26)Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimers dementia. Proc Natl Acad Sci U S A. 2004; 101: 284-9
PubMed CrossRef
医中誌リンクサービス
27)Filippini N, MacIntosh BJ, Hough MG, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2003; 106: 7209-14
PubMed
医中誌リンクサービス
28)Sheline YI, Morris JC, Snyder AZ, et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreaed CSF Abeta42. J Neurosci. 2010; 30: 17035-40
PubMed CrossRef
医中誌リンクサービス
29)Vemuri P, Wiste HJ, Weigand SD, et al. Serial MRI and CSF biomarkers in normal aging, MCI, and AD. Neurology. 2010; 75: 143-51
PubMed CrossRef
医中誌リンクサービス
30)Howieson DB, Carlson NE, Moore MM, et al. Trajectory of mild cognitive impairment onset. J Int Neuropsychol Soc. 2008; 14: 192-8
PubMed
医中誌リンクサービス
31)Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimers disease neuroimaging initiative subjects. Ann Neurol. 2009; 65: 403-13
PubMed CrossRef
医中誌リンクサービス
32)Sperling RA, LaViolette PS, OKeefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009; 63: 178-88
PubMed CrossRef
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp